Recombinant Human TREML2/TLT-2 (C-Fc)

Recombinant Human TREML2/TLT-2 (C-Fc)

SKU: CC39-10ug
Recombinant Human TREML2 is produced by our Mammalian expression system and the target gene encoding Gly19-Ser268 is expressed with a Fc tag at the C-terminus. Bon Opus Cat. #CC39
  • Accession Number

  • Background

    Trem-like transcript 2 protein (TLT2), also known as Triggering receptor expressed on myeloid cells-like protein 2, TLT2 and C6orf76, is single-pass type I membrane protein. TREML2 contains one Ig-like V-type domain, which can be induced in CD4 T-cell by concanavalin-A. As a cell surface receptor, TREML2 may play a role in the innate and adaptive immune response. TREML2 also acts as a counter-receptor for CD276 and interaction with CD276 on T-cells enhances T-cell activation. It has shown that TREML2 may be involved in the innate immune response based on its expression profile and the fact that it is up-regulated in response to inflammation.
  • Expression

    Human Cells
  • Packaging

  • Formulation

    Lyophilized from a 0.2 μm filtered solution of PBS, pH 7.4 .
  • ALTnames

    Trem-like transcript 2 protein,TLT2, Triggering receptor expressed on myeloid cells-like protein 2, TLT2,C6orf76,

(800) 943-6396

150 Essex St, Millburn, NJ 07041, USA

©2020 by Bon Opus Biosciences, LLC.